Author:
Kurzrock Razelle,Kantarjian Hagop M.,Kesselheim Aaron S.,Sigal Ellen V.
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Stadtmauer, E. A. et al. Conventional-dose chemotherapy compared with high dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group. N. Engl. J. Med. 342, 1069–1076 (2000).
2. Kurzrock, R., Kantarjian, H. & Stewart, D. J. A cancer trial scandal and its regulatory backlash. Nat. Biotechnol. 32, 27–31 (2014).
3. Stewart, D. J., Whitney, S. N. & Kurzrock, R. Equipoise lost: ethics, costs, and the regulation of cancer clinical research. J. Clin. Oncol. 28, 2925–2935 (2010).
4. Tsimberidou, A. M., Braiteh, F., Stewart, D. J. & Kurzrock, R. Ultimate fate of oncology drugs approved by the US Food and Drug Administration without a randomized trial. J. Clin. Oncol. 27, 6243–6250 (2009).
5. FDA. CFR - Code of Federal Regulations Title 21 https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=312&showFR=1&subpartNode=21:5.0.1.1.3.5 (2019).
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献